Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis [Phase 2]
A Phase 2 trial evaluating sertaconazole 2% cream for improving symptoms associated with atopic dermatitis has completed.
-
CLINICAL_TRIALS withdrawal · 2015-05-19Clinical Trial Update: A Psychoeducational Prevention for the Treatment of Atopic Dermatitis in Youth and Their Families [NA]
The clinical trial 'A Psychoeducational Prevention for the Treatment of Atopic Dermatitis in Youth and Their Families' has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-05-12Clinical Trial Update: Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy [Phase 4]
A Phase 4 clinical trial evaluating concurrent Altabax (retapamulin) with topical low-potency corticosteroids versus corticosteroid monother…
-
CLINICAL_TRIALS research · 2015-05-07Clinical Trial Update: Regulatory T Cells (Tregs) in Polymorphic Light Eruption
A completed clinical trial from Medical University of Graz examining regulatory T cells in polymorphic light eruption, with related conditio…
-
FDA approval · 2015-04-29FDA Approved: TACROLIMUS — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
The FDA approved a supplemental application for tacrolimus from E. Fougera & Co., a division of Fougera Pharmaceuticals, LLC. The action per…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-22Clinical Trial Update: Molecular and Cellular Characterization of Spongiotic Dermatitis
A completed clinical trial characterizing the molecular and cellular features of spongiotic dermatitis across multiple inflammatory skin dis…
-
CLINICAL_TRIALS trial_result · 2015-04-20Clinical Trial Update: Effectiveness of Melatonin for Sleep Disturbances in Children With Atopic Dermatitis [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial evaluating the effectiveness of melatonin to improve sleep disturbances in children with atopic dermatitis…
-
FDA approval · 2015-04-20FDA Approved: DESOXIMETASONE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved the original application for desoximetasone from Padagis Israel Pharmaceuticals Ltd, granting approval for a topical corticoste…
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: Comparison of Video-Based Versus Written Patient Education on Atopic Dermatitis [NA]
A completed trial comparing video-based versus written patient education for managing atopic dermatitis.
-
FDA approval · 2015-04-15FDA Approved: DESOXIMETASONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for desoximetasone submitted by Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2015-04-14Clinical Trial Update: Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
A completed clinical trial examining whether the severity of pediatric psoriasis affects childhood body mass index, with atopic dermatitis l…
-
CLINICAL_TRIALS trial_result · 2015-04-08Clinical Trial Update: Vitamin D Deficiency and Atopic Dermatitis [NA]
Clinical trial update for a study on vitamin D deficiency and atopic dermatitis; the study was terminated with results posted in 2015.
-
CLINICAL_TRIALS withdrawal · 2015-04-07Clinical Trial Update: Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for Atopic Dermatitis [Phase 4]
A Phase 4 long-term safety trial evaluating tacrolimus ointment for atopic dermatitis was withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: Photophoresis Versus Ciclosporine in Severe Atopic Dermatitis [NA]
A completed clinical trial comparing photopheresis with ciclosporine in patients with severe atopic dermatitis.
-
CLINICAL_TRIALS trial_result · 2015-03-17Clinical Trial Update: Prevention Allergic Disease of Infant With Probiotics During Pregnancy and Neonatal Period [Phase 3]
Phase 3 trial evaluating whether maternal and neonatal probiotics prevent allergic diseases in infants; the study (NCT00325273) is completed…
-
CLINICAL_TRIALS research · 2015-03-06Clinical Trial Update: Topical Treatment With Fresh Human Milk Versus Emollient on Atopic Eczema Spots in Young Children [NA]
A completed clinical trial comparing topical fresh human milk versus an emollient for treating atopic dermatitis spots in young children.
-
CLINICAL_TRIALS trial_result · 2015-03-05Clinical Trial Update: DEC033 Study Product for Mild to Moderate Eczema An Open-label, Adaptive-design Pilot Study [Phase 1]
Open-label, adaptive-design Phase 1 trial evaluating DEC033 for mild to moderate eczema has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: Impact of Vitamin D Supplementation on Severity of Pediatric Atopic Dermatitis [NA]
Clinical trial evaluating the impact of vitamin D3 (cholecalciferol) supplementation on the severity of pediatric atopic dermatitis has comp…
-
FDA approval · 2015-02-18FDA Approved: MOMETASONE FUROATE — Supplemental Application (Encube Ethicals, Inc.)
FDA approved a supplemental application for mometasone furoate from Encube Ethicals, Inc., granting approval of a supplemental ANDA for this…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis [Phase 4]
Phase 4 clinical trial in children and adolescents with mild to moderate atopic dermatitis conducted by Bayer has completed.
-
FDA approval · 2015-01-22FDA Approved: HYDROCORTISONE — Supplemental Application (Allegis Holdings LLC)
FDA approved a supplemental application for HYDROCORTISONE lotion from Allegis Holdings LLC.
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD) [Phase 2]
Phase 2 clinical trial update assessing the efficacy and safety of different concentrations of Mapracorat ointment over 4 weeks in patients …
-
CLINICAL_TRIALS research · 2015-01-21Clinical Trial Update: The Cork BASELINE Birth Cohort Study
Clinical trial update for the Cork BASELINE Birth Cohort Study listing Food allergy, Atopic dermatitis, and Obesity as conditions studied.
-
FDA approval · 2015-01-20FDA Approved: BETAMETHASONE VALERATE — Supplemental Application (E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC)
The FDA approved a supplemental application for Betamethasone valerate from E. Fougera & Co., a division of Fougera Pharmaceuticals, LLC. Th…
-
CLINICAL_TRIALS trial_result · 2015-01-09Clinical Trial Update: Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in Children [Phase 3]
A Phase 3 study evaluating twice-weekly topical fluticasone to reduce relapse in children with atopic dermatitis has been terminated.